Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Need quick cash? Check out these ways to earn money on the same day and start generating income in no time.
19,298 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
The Nasdaq down from high has created a disciplined buying moment for patient investors. This guide highlights five t...
Disney reports stronger-than-expected Q2 2026 results, lifting the stock 8% in early trading as streaming and parks r...
At Consensus 2026 in Miami, Pi Network’s Dr. Chengdiao Fan laid out a vision for utility-driven tokens and real-world...
In today’s stock market today, Nokia priced lower by about 6% as traders weigh AI hype against fundamentals. This pie...
Bitcoin profit-taking is picking up as the bear-market rally continues. CryptoQuant reports rising on-chain profits a...
SUI surged 37% over the past seven days, powered by institutional staking inflows and a protocol upgrade that enables...
An 18-year-old Barcelona star headlines a week of victory, celebrity moments, and a bold political gesture, reshaping...
Palantir posted solid Q1 2026 growth, but the stock fell as investors priced in a valuation reset and AI competition....
Is Fortinet stock a buy or a sell? This fortinet stock analysis: sell dives into growth prospects, valuation, and pra...
Nvidia stock hits highs, renewing the debate over whether now is the moment to buy. This guide breaks down what's dri...
Alumis stock over 300% has turned heads after a big healthcare investor trimmed its stake. This article breaks down w...